A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status:
Completed
Trial end date:
2017-06-19
Target enrollment:
Participant gender:
Summary
The purpose of this sub-study of MB130-045 is to determine the pharmacokinetic effects,
pharmacodynamic effects, efficacy and safety of BMS-986036 20 mg QD in subjects with
Non-alcoholic Steatohepatitis (NASH)